EGFR/HER2 tyrosine kinase inhibitor

This page covers all EGFR/HER2 tyrosine kinase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting EGFR, HER2, HER2.

Targets

EGFR, HER2 · HER2

Phase 3 pipeline (2)

• Placebo PF00299804 · Pfizer · Oncology
  PF00299804 is a small-molecule tyrosine kinase inhibitor that targets EGFR and HER2 to block cancer cell growth signaling.
• Pimicotinib(ABSK021) · Abbisko Therapeutics Co, Ltd · Oncology
  Pimicotinib is a tyrosine kinase inhibitor that targets HER2 (human epidermal growth factor receptor 2) to inhibit cancer cell growth and proliferation.

Patent intelligence

• her2 tyrosine kinase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates